How Cell-Penetrating Peptides Interact With Membranes: Implications for Oral Insulin Delivery
Three carrier peptides used for oral insulin delivery each interacted differently with model cell membranes — penetratin caused irreversible clustering while its analogues were reversible — but none disrupted the membranes, supporting their safety for drug delivery.
Quick Facts
What This Study Found
All three cell-penetrating peptides — penetratin, shuffle, and penetramax — adsorbed to lipid bilayer surfaces and induced liposome clustering at specific peptide-to-lipid ratios. However, the nature of their interactions differed significantly: penetratin caused irreversible clustering, penetramax caused partly reversible clustering, and shuffle caused fully reversible clustering.
Shuffle and penetramax additionally caused liposome shape deformation, while penetratin did not. Importantly, none of the peptides disrupted liposome integrity under any tested conditions, meaning they interact with membranes without destroying them — a critical requirement for safe drug delivery applications.
Key Numbers
How They Did This
Peptide-liposome interactions were studied using small-angle neutron scattering (SANS) and fluorescence lifetime imaging microscopy (FLIM). Liposomes served as model cell membranes. The three carrier peptides (penetratin, shuffle, and penetramax) were tested at various peptide-to-lipid ratios to characterize membrane adsorption, clustering behavior, reversibility, and structural integrity.
Why This Research Matters
Oral delivery of peptide drugs like insulin could eliminate the need for daily injections for millions of diabetes patients. Understanding exactly how carrier peptides interact with gut cell membranes — without damaging them — is essential for designing safe and effective oral peptide delivery systems. The reversibility differences between these peptides could influence which is best suited for clinical use.
The Bigger Picture
Oral delivery of peptide therapeutics is one of the biggest challenges in pharmaceutical science. Cell-penetrating peptides represent one of the most promising strategies for enabling oral bioavailability of drugs like insulin. This biophysical study provides the mechanistic foundation needed to rationally design and optimize carrier peptide sequences for this purpose, moving beyond trial-and-error approaches.
What This Study Doesn't Tell Us
Liposomes are simplified models that do not capture the full complexity of living cell membranes, which contain proteins, sugars, and asymmetric lipid compositions. The study did not assess whether the observed membrane interactions translate to actual drug transport across biological barriers. In vivo conditions including enzymes, mucus, and pH changes in the gut were not modeled.
Questions This Raises
- ?Does the reversibility of membrane clustering correlate with better drug delivery efficiency or safety in living tissue?
- ?Which of these carrier peptides — penetratin, shuffle, or penetramax — is most effective at transporting insulin across real intestinal epithelium?
- ?Can the sequence modifications that make shuffle and penetramax reversible be further optimized for clinical oral peptide delivery?
Trust & Context
- Key Stat:
- No membrane disruption All three cell-penetrating peptides interacted with liposome membranes without breaking them — a key safety requirement for oral drug delivery
- Evidence Grade:
- This is a biophysical laboratory study using model membrane systems (liposomes). While the techniques are sophisticated (SANS, FLIM), the findings are mechanistic and have not been validated in biological tissue or in vivo models.
- Study Age:
- Published in 2023, this study reflects the current state of biophysical research into peptide-based drug delivery and uses advanced techniques to address a long-standing question in the oral peptide delivery field.
- Original Title:
- Carrier peptide interactions with liposome membranes induce reversible clustering by surface adsorption and shape deformation.
- Published In:
- Journal of colloid and interface science, 650(Pt B), 1821-1832 (2023)
- Authors:
- Diedrichsen, Ragna Guldsmed(2), Vetri, Valeria(2), Prévost, Sylvain(2), Foderà, Vito, Nielsen, Hanne Mørck
- Database ID:
- RPEP-06840
Evidence Hierarchy
Frequently Asked Questions
Why can't you just take insulin as a pill?
Insulin is a peptide that gets destroyed by stomach acid and digestive enzymes before it can be absorbed. Even if it survives digestion, it's too large to easily cross the gut lining into the bloodstream. Carrier peptides like those in this study can potentially shuttle insulin across the gut barrier by interacting with cell membranes in a way that allows the drug to pass through without damaging the cells.
What makes these three carrier peptides different from each other?
Penetratin is the original cell-penetrating peptide, while shuffle and penetramax are modified versions with rearranged amino acid sequences. Despite their similarities, they interact with membranes quite differently: penetratin sticks permanently to membranes, shuffle's effects are fully reversible, and penetramax falls in between. These differences could determine which is safest and most effective for carrying drugs across biological barriers.
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-06840APA
Diedrichsen, Ragna Guldsmed; Vetri, Valeria; Prévost, Sylvain; Foderà, Vito; Nielsen, Hanne Mørck. (2023). Carrier peptide interactions with liposome membranes induce reversible clustering by surface adsorption and shape deformation.. Journal of colloid and interface science, 650(Pt B), 1821-1832. https://doi.org/10.1016/j.jcis.2023.07.078
MLA
Diedrichsen, Ragna Guldsmed, et al. "Carrier peptide interactions with liposome membranes induce reversible clustering by surface adsorption and shape deformation.." Journal of colloid and interface science, 2023. https://doi.org/10.1016/j.jcis.2023.07.078
RethinkPeptides
RethinkPeptides Research Database. "Carrier peptide interactions with liposome membranes induce ..." RPEP-06840. Retrieved from https://rethinkpeptides.com/research/diedrichsen-2023-carrier-peptide-interactions-with
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.